These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12097545)

  • 1. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson R; Cavalcanti R; Brunton JL; Bast DJ; de Azavedo JC; Kibsey P; Fleming C; Low DE
    N Engl J Med; 2002 Mar; 346(10):747-50. PubMed ID: 11882730
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Zhanel GG; Hoban DJ; Chan CK
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102063
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Tillotson GS; Zhao X; Drlica K
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102062
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Hutchinson J
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102064
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
    Anderson KB; Tan JS; File TM; DiPersio JR; Willey BM; Low DE
    Clin Infect Dis; 2003 Aug; 37(3):376-81. PubMed ID: 12884162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
    Low DE
    Clin Infect Dis; 2004 May; 38 Suppl 4():S357-62. PubMed ID: 15127370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Rubinstein E
    J Antimicrob Chemother; 2003 May; 51(5):1307-8; author reply 1308-9. PubMed ID: 12697636
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.
    de Cueto M; Rodríguez JM; Soriano MJ; López-Cerero L; Venero J; Pascual A
    J Clin Microbiol; 2008 Apr; 46(4):1558-60. PubMed ID: 18287316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae.
    Wortmann GW; Bennett SP
    Clin Infect Dis; 1999 Dec; 29(6):1599-600. PubMed ID: 10585837
    [No Abstract]   [Full Text] [Related]  

  • 14. Levofloxacin failure in a patient with pneumococcal pneumonia.
    Empey PE; Jennings HR; Thornton AC; Rapp RP; Evans ME
    Ann Pharmacother; 2001 Jun; 35(6):687-90. PubMed ID: 11408985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Naba MR; Araj GF; Baban TA; Tabbarah ZA; Awar GN; Kanj SS
    J Infect Public Health; 2010; 3(3):113-7. PubMed ID: 20869671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
    Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of macrolide resistance in Streptococcus pneumoniae.
    Nuermberger EL; Bishai WR
    J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
    [No Abstract]   [Full Text] [Related]  

  • 19. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 20. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.